Publicaciones en colaboración con investigadores/as de Örebro University (1)

2021

  1. Dapagliflozin as an adjunct therapy to insulin in patients with type 1 diabetes mellitus: Efficacy and safety of this combination

    touchREVIEWS in Endocrinology, Vol. 17, Núm. 1, pp. 12-20